Delivering Multiparametric MRI-Guided High-Dose-Rate Brachytherapy Boost in Nonmetastatic Prostate Cancer

被引：0
|
作者：
Mason, J. [1 ]
Rodda, S. Lakshmi [1 ]
Sethugavalar, B. [1 ]
Al-Qaisieh, B. [1 ]
Bownes, P. [1 ]
Smith, J. [1 ]
Franks, K. [1 ]
Carey, B. [1 ]
Bottomley, D. [1 ]
Henry, A. M. [1 ]
机构：
[1] St Jamess Inst Oncol, Leeds, W Yorkshire, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1313
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2505
引用
收藏
页码：S413 / S413
页数：1
相关论文
共 50 条
  • [31] HIGH-DOSE-RATE BRACHYTHERAPY BOOST FOR PROSTATE CANCER: COMPARISON OF TWO DIFFERENT FRACTIONATION SCHEMES
    Kaprealian, Tanta
    Weinberg, Vivian
    Speight, Joycelyn L.
    Gottschalk, Alexander R.
    Roach, Mack, III
    Shinohara, Katsuto
    Hsu, I. -Chow
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 222 - 227
  • [32] Partial Volume High-dose-rate Brachytherapy Boost for Localized Prostate Cancer: Toxicity and Outcome
    Schick, U.
    Popowski, Y.
    Nouet, P.
    Ares, C.
    Dipasquale, G.
    Bieri, S.
    Rouzaud, M.
    Khan, H.
    Weber, D. C.
    Miralbell, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S356 - S357
  • [33] Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life
    Sanmamed, Noelia
    Chung, Peter
    Berlin, Alejandro
    Adleman, Jenna
    Borg, Jette
    Lao, Bernadeth
    Ghai, Sangeet
    Weersink, Robert
    Simeonov, Anna
    Rink, Alex
    Menard, Cynthia
    Helou, Joelle
    BRACHYTHERAPY, 2019, 18 (04) : 477 - 483
  • [34] Validation of MRI to TRUS registration for high-dose-rate prostate brachytherapy
    Poulin, Eric
    Boudam, Karim
    Pinter, Csaba
    Kadoury, Samuel
    Lasso, Andras
    Fichtinger, Gabor
    Menard, Cynthia
    BRACHYTHERAPY, 2018, 17 (02) : 283 - 290
  • [35] Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
    Yamazaki, Hideya
    Masui, Koji
    Suzuki, Gen
    Yoshida, Ken
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 24 : 10 - 10
  • [36] Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
    Willigenburg, Thomas
    van Son, Marieke J.
    van de Pol, Sandrine M. G.
    Eppinga, Wietse S. C.
    Lagendijk, Jan J. W.
    de Boer, Hans C. J.
    Moerland, Marinus A.
    van Zyp, Jochem R. N. van der Voort
    Peters, Max
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 30 : 7 - 14
  • [37] The emerging role of high-dose-rate brachytherapy for prostate cancer
    Morton, GC
    CLINICAL ONCOLOGY, 2005, 17 (04) : 219 - 227
  • [38] Salvage high-dose-rate brachytherapy for recurrent prostate cancer
    Kaprin, A. D.
    Ivanov, S. A.
    Karyakin, O. B.
    Obuhov, A. A.
    Biryukov, V. A.
    Borysheva, N. B.
    Sanin, D. B.
    Lepilina, O. G.
    Smolkin, A. L.
    Dem'yanovich, A., V
    Minaeva, N. G.
    Mikhaylovskiy, N., V
    ONKOUROLOGIYA, 2020, 16 (04): : 112 - 119
  • [39] Salvage high-dose-rate brachytherapy for prostate cancer recurrence
    Wojcieszek, P.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S355 - S356
  • [40] A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?
    Tang, Johann I.
    Williams, Scott G.
    Tai, Keen Hun
    Dean, Joanne
    Duchesne, Gillian M.
    BRACHYTHERAPY, 2006, 5 (04) : 256 - 261
12345